Debt-to-equity of Day One Biopharmaceuticals, Inc. from 31 Mar 2022 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Day One Biopharmaceuticals, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2022 to 31 Dec 2025.
  • Day One Biopharmaceuticals, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 13%, a 12% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Day One Biopharmaceuticals, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 13% -1.7% -12% 31 Dec 2025
Q3 2025 14% +0.34% +2.6% 30 Sep 2025
Q2 2025 12% -1.3% -10% 30 Jun 2025
Q1 2025 15% +7.4% +100% 31 Mar 2025
Q4 2024 15% +8% +115% 31 Dec 2024
Q3 2024 13% +7% +113% 30 Sep 2024
Q2 2024 13% +7.4% +125% 30 Jun 2024
Q1 2024 7.4% +2.2% +43% 31 Mar 2024
Q4 2023 7% +2.7% +63% 31 Dec 2023
Q3 2023 6.2% +2.4% +63% 30 Sep 2023
Q2 2023 5.9% +2.9% +99% 30 Jun 2023
Q1 2023 5.2% +2.8% +117% 31 Mar 2023
Q4 2022 4.3% 31 Dec 2022
Q3 2022 3.8% 30 Sep 2022
Q2 2022 3% 30 Jun 2022
Q1 2022 2.4% 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.